搜索筛选:
搜索耗时2.4995秒,为你在为你在102,285,761篇论文里面共找到 2 篇相符的论文内容
发布年度:
[期刊论文] 作者：Zhong-jie Li,Hui-qi Dai,Xiao-wei Huang,Ji Feng,Jing-huan Deng,Zi-xuan Wang,Xiao-mei Yang,Yu-jia Liu,Yong,
来源：中国药理学报（英文版） 年份：2021
Sorafenib is the first-line medication for advanced hepatocellular carcinoma(HCC),but it can only extend limited survival.It is imperative to find a combination...
[期刊论文] 作者：Ji Feng,Pei-zhi Lu,Guang-zhi Zhu,Shing Chung Hooi,Yong Wu,Xiao-wei Huang,Hui-qi Dai,Pan-hong Chen,Zhong-jie,
来源：中国药理学报（英文版） 年份：2021
Sorafenib is the first-line treatment of advanced hepatocellular carcinoma(HCC).However,there is a lack of validated biomarkers to predict sorafenib sensitivity...
相关搜索：
